Patient experience survey (pain medicine) - summary form
Patient experience survey (pain medicine) - summary form
ANZCA Strategic Plan 2018-2022
The ANZCA Strategic Plan 2018-2022 guides our college-wide business activity. It's the result of comprehensive consultation and engagement within the ANZCA community and beyond.
EPA 4 Perioperative pain relief - EPA Review
EPA 4 Perioperative pain relief - EPA Review
Anaesthesia and smoking
Smokers are at increased risk of respiratory, cardiac and wound-related complications following surgery.
Find out more
Mortality Sub-committee
The Mortality Sub-committee was developed as a collaboration between the chairs of established anaesthetic mortality committees in Australia, under the auspices of ANZCA. The group is chaired by Dr Simon Jenkins, and includes the chairs of all established anaesthetic mortality...
Find out more
Propofol anaphylaxis
ANZCA has been notified of an episode of life-threatening anaphylaxis, most likely triggered by propofol, in a previously well 12 year-old boy with no allergy history. Propofol anaphylaxis is extremely rare but possible.
Find out more
Ventolin metered dose inhalers (AU)
Important information on changes to the design of Salbutamol (Ventolin) metered dose inhalers (MDIs/‘puffers’) in Australia.
Find out more
Neuroanaesthesia SIG
The Neuroanaesthesia SIG exists to foster interest in matters relating to the perioperative care and anaesthesia of patients with intracranial and spinal pathology. This includes the application of basic and translational science relevant to clinical anaesthesia.
Find out more
New Zealand recall: CareSens KetoSens Test Strip – specific batch returns false readings
Recall in New Zealand of CareSens KetoSens Test Strips batch UJ03PBXNG, which give false (too high) readings of patient blood ketones.
Find out more
Reg 27 - Performance assessment of anaesthetists and pain medicine physicians